APA citiranje

Taymans, J., & Greggio, E. (2016). LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand? Curr Neuropharmacol.

Citação norma Chicago

Taymans, Jean-Marc, and Elisa Greggio. "LRRK2 Kinase Inhibition As a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?" Curr Neuropharmacol 2016.

MLA citiranje

Taymans, Jean-Marc, and Elisa Greggio. "LRRK2 Kinase Inhibition As a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?" Curr Neuropharmacol 2016.